Open-Label Safety and Tolerability Study of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome
Public ClinicalTrials.gov record NCT03444038. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Open-Label Safety and Tolerability Study of Optimized Doses of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome
Study identification
- NCT ID
- NCT03444038
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Neurocrine Biosciences
- Industry
- Enrollment
- 85 participants
Conditions and interventions
Conditions
Interventions
- Valbenazine Drug
Drug
Eligibility (public fields only)
- Age range
- 6 Years to 18 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 7, 2018
- Primary completion
- Jul 11, 2019
- Completion
- Jul 11, 2019
- Last update posted
- Feb 22, 2022
2018 – 2019
United States locations
- U.S. sites
- 36
- U.S. states
- 19
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Neurocrine Clinical Site | Sun City | Arizona | 85351 | — |
| Neurocrine Clinical Site | Anaheim | California | 92805 | — |
| Neurocrine Clinical Site | San Diego | California | 92108 | — |
| Neurocrine Clinical Site | Santa Ana | California | 92705 | — |
| Neurocrine Clinical Site | Santa Clarita | California | 91321 | — |
| Neurocrine Clinical Site | New Haven | Connecticut | 06510 | — |
| Neurocrine Clinical Site | Boca Raton | Florida | 33431 | — |
| Neurocrine Clinical Site | Gulf Breeze | Florida | 32561 | — |
| Neurocrine Clinical Site | Hialeah | Florida | 33013 | — |
| Neurocrine Clinical Site | Orlando | Florida | 32801 | — |
| Neurocrine Clinical Site | Orlando | Florida | 32803 | — |
| Neurocrine Clinical Site | St. Petersburg | Florida | 33701 | — |
| Neurocrine Clinical Site | Tampa | Florida | 33614 | — |
| Neurocrine Clinical Site | Chicago | Illinois | 60634 | — |
| Neurocrine Clinical Site | Naperville | Illinois | 60563 | — |
| Neurocrine Clinical Site | Iowa City | Iowa | 52242 | — |
| Neurocrine Clinical Site | Leawood | Kansas | 66206 | — |
| Neurocrine Clinical Site | Ann Arbor | Michigan | 48105 | — |
| Neurocrine Clinical Site | Bloomfield Hills | Michigan | 48371 | — |
| Neurocrine Clinical Site | St Louis | Missouri | 63110 | — |
| Neurocrine Clinical Site | Lincoln | Nebraska | 68526 | — |
| Neurocrine Clinical Site | Nashua | New Hampshire | 03060 | — |
| Neurocrine Clinical Site | Mount Arlington | New Jersey | 07856 | — |
| Neurocrine Clinical Site | Voorhees Township | New Jersey | 08043 | — |
| Neurocrine Clinical Site | New York | New York | 10036 | — |
| Neurocrine Clinical Site | The Bronx | New York | 10467 | — |
| Neurocrine Clinical Site | Durham | North Carolina | 27705 | — |
| Neurocrine Clinical Site | Mason | Ohio | 45040 | — |
| Neurocrine Clinical Site | Oklahoma City | Oklahoma | 73112 | — |
| Neurocrine Clinical Site | Charleston | South Carolina | 29414 | — |
| Neurocrine Clinical Site | Dallas | Texas | 75243 | — |
| Neurocrine Clinical Site | Houston | Texas | 77030 | — |
| Neurocrine Clinical Site | Houston | Texas | 77058 | — |
| Neurocrine Clinical Site | San Antonio | Texas | 78249 | — |
| Neurocrine Clinical Site | Everett | Washington | 98201 | — |
| Neurocrine Clinical Site | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03444038, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 22, 2022 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03444038 live on ClinicalTrials.gov.